Li Lab: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(85 intermediate revisions by the same user not shown)
Line 6: Line 6:
<div style="float:left;margin-left:0.3em;margin-right:0.7em">
<div style="float:left;margin-left:0.3em;margin-right:0.7em">


== '''Wei Li's Computational Epigenomics Lab''' ==  
== '''Computational Epigenomics and Transcriptomics Lab (PI: Wei Li)''' ==  


[http://www.bcm.edu/cancercenter/ Dan L. Duncan Cancer Center], [http://www.bcm.edu/mcb/index.html Department of Molecular and Cellular Biology], [http://www.bcm.edu/ Baylor College of Medicine]
[http://www.bcm.edu/cancercenter/ Dan L. Duncan Cancer Center], [http://www.bcm.edu/mcb/index.html Department of Molecular and Cellular Biology], [http://www.bcm.edu/ Baylor College of Medicine]
Line 15: Line 15:


==Recent News==
==Recent News==
. 02/2012Yuanxin's epigenetic paper with Katrin Chua lab at Stanford was accepted to '''Nature'''. Two years of hard work finally paid off!
. 06/2014Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to '''Cell Stem Cell '''.  


. 02/2012Liguo Wang was offered a '''tenure-track Assistant Professor''' position at Mayo Clinic. Congratulations!
. 06/2014Zheng's alternative splicing paper (with the Cooper Lab) is accepted to '''Molecular Cell '''.  


. 02/2012Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!
. 04/2014:  Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in '''Nucleic Acids Research'''.
 
. 02/2014:  DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in '''Cell Stem Cell'''.
 
. 02/2014Zheng's collaborative work on alternative splicing in heart development is accepted to '''Nature Communications'''.
 
. 02/2014:  Zheng's brain tumor 3'UTR regulator paper is accepted to '''Nature'''. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.
 
. 02/2014:  Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.
 
. 02/2014:  Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to '''Cell Stem Cell'''.
 
. 01/2014:  Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to '''Genome Biology'''.
 
. 01/2014:  Our collaborative work on Breast Cancer Epigenetics is accepted to '''Science Translational Medicine'''.
 
. 01/2014:  Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to '''Nature'''. This work links transcription elongation to tumor suppression.
 
. 12/2013: Kaifu's aging nucleosome paper is accepted to ''' Genes & Development'''
 
. 12/2013: We received a 5-year NIH/NHGRI '''R01''' grant (scored at 6 percentile in its first submission) to study DNA Methylation


. 11/2011: Yuanxin's RRBSMAP paper was accepted to '''Bioinformatics'''.
. 11/2013: Wei will serve on the Editorial Board of '''Molecular Endocrinology'''


. 09/2011Wei Li was promoted to tenured '''Associate Professor''' at BCM. Cheers!
. 09/2013Deqiang's DNA methylation Canyon paper is accepted to '''Nature Genetics'''.


. 09/2011Deqiang's DNA methylation paper with Peggy Goodell lab was accepted to '''Nature Genetics'''.  
. 09/2013Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to '''Bioinformatics'''.


. 08/2011Kaifu's NSD2 epigenetic paper with Or Gozani lab at Stanford was accepted to '''Molecular Cell'''.
. 08/2013Kadir's p53 paper is accepted to '''Nucleic Acids Research'''


. 08/2011A '''NIH R01 grant''' was funded. We will work with Dr. Wang at the Ohio State University to understand the role of histone methylations in prostate cancer.
. 06/2013Zheng's TCGA RNA-seq bioinformatics paper is under review in '''Nature Biotechnology'''.


. 07/2011Liguo's FoxA1 cistrome paper was accepted to '''Cancer Research'''.
. 01/2013[http://www.bcm.edu/news/item.cfm?newsID=6723 BCM News] and  [http://epigenie.com/danpos-reveals-dynamic-nucleosomes Epigenie Headline] about our recent work on nucleosome dynamics.


. 07/2011: See our '''[http://www.genomeweb.com/node/973004 Genomic Regulation Technical Guide]''' on Genome Technology magazine
. 12/2012: Liguo and HJ's CPAT RNA coding potential prediction paper is accepted to '''Nucleic Acids Research'''.


. 07/2011: Dr. Zheng Xia will join us as a postdoc fellow. Zheng has PhD in Control Theory and Engineering Computer Science from Zhejiang University in China. Welcome!
. 11/2012: Kaifu's nucleosome methodology paper DANPOS is accepted to '''Genome Research'''.


. 05/2011Dr.Bert O'Malley's coregulator network paper was published in '''Cell'''. Wei is a co-author on the paper.
. 10/2012Kaifu's promoter nucleosome paper is accepted to '''Genome Research'''.


. 04/2011Liguo's Prostate Cancer RNA-seq paper was officially accepted to  '''PNAS'''.
. 09/2012A '''NIH R01 grant''' was funded. We will work with Dr. Issa at Temple Univ. to understand DNA methylation in Cancer.


. 03/2011: Our Texas '''CPRIT Multi-Investigator grant''' was funded with a total direct cost of  ~$10M for 5 years. This project will bring together a "dream team" in cancer epigenetic research.  We will direct the bioinformatics component for LONESTAR.  
. 08/2012: A mouse ES nucleosome paper from Kaestner lab at Upenn is accepted to '''Cell'''. Kaifu and Wei used DANPOS to analyze the data and were listed as co-authors.


. 01/2011: Yuanxin's fragile nucleosome paper was accepted to  '''Genome Research'''.
. 08/2012: Dr. Benjamin Rodriguez will join us as a '''Postdoc Associate'''. Ben has PhD in Integrated Biomedical Science from the Ohio State Univ. Welcome!


. 01/2011Yuanxin and Liguo's Atoh1 targetome paper was accepted to '''PNAS'''.
. 08/2012A '''Mazzone Award ''' is funded. We will work with Dr. Balk at Harvard Medical School to understand the molecular features of aggressive prostate cancer.
. 06/2012: Liguo's RNA-seq Quality Control paper is accepted to '''Bioinformatics'''.


. 12/2010Liguo's fly RNA-seq paper was published in  '''Genome Research'''.
. 06/2012A '''NIH R01 grant''' is funded. We will work with Dr. Goodell at BCM to understand DNA methylation in Hematopoietic Stem Cell.


. 10/2010:  A Texas '''CPRIT grant''' was funded. We will work with Dr. Goodell at BCM to understand DNA Methylgransferase 3B in normal and malignant hematopoiesis.  
. 04/2012:  A '''NIH R01 grant''' is funded. We will work with Dr. Dent at MD Anderson to define USP22 functions during mammalian development.


. 08/2010Our '''Pilot Project''' was funded by a NIH Stem Cell P01 Grant.  
. 04/2012Dr.Dean Tang's prostate cancer stem cell paper is accepted in '''Cell Stem Cell'''. Wei is a co-author.


. 07/2010The DNA methylation platform comparision paper was accepted to '''Nature Biotechnology'''.
. 02/2012Yuanxin's epigenetic paper with Katrin Chua lab at Stanford is accepted to '''Nature'''. Two years of hard work finally paid off!


. 02/2012:  Liguo Wang is offered a '''tenure-track Assistant Professor''' position at Mayo Clinic. Congratulations!


. 02/2012:  Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!


[[Image:Banner.jpg‎‎]]
[[Image:Banner.jpg‎‎]]


[http://openwetware.org/wiki/Li_Lab:news News Archive]
[http://openwetware.org/wiki/Li_Lab:news News Archive]
Line 80: Line 103:
<div style="border-bottom: 1px dashed #9999CC;">
<div style="border-bottom: 1px dashed #9999CC;">


Our lab is focused on the design and application of bioinformatics algorithms to elucidate global regulatory mechanism by integrating data from ChIP-seq, DNA methylation, Nucleosome positioning, and RNA-seq. We are also working with bench and clinical collaborators to understand epigenetic gene regulation and transcription dynamics in various biological processes and disease models.  
Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.
 
We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.
 
In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.
 
* Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
 
* DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.  


We have developed a number of widely used algorithms to detect and annotate genome-wide cis-regulatory regions, including a Hidden Markov Model ('''Bioinformatics''' 2005) and MAT ('''PNAS''' 2006) for analyzing ChIP-chip experiments on genome tiling arrays, CEAS ('''NAR''' 2006) for cis-regulatory element annotation, xMAN ('''BMC Genomics''' 2008) for microarray probe mapping, MACS ('''Genome Biology''' 2008) for model based analysis of ChIP-seq, BSMAP ('''BMC Bioinformatics''' 2009) for DNA methylation analysis using Bisulfite-seq, MMES ('''PLoS ONE''' 2010) for alternative splicing using RNA-seq, and fragile nucleosomes ('''Genome Re'''s 2011) using MNase-seq. These algorithms have gathered thousands of academic users worldwide and hundreds of citations, including > 30 papers in Cell and Nature series. We are currently working on bioinformatics development for 1) Transcription factor binding and histone modifications (ChIP-seq); 2) DNA methylation at single nucleotide resolution (Bisulfite-seq); 3) Nucleosome remodeling (Mnase-seq); 4) Alternative splicing (RNA-seq).
* Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.


We have extensive experience in collaborative research, such as Estrogen Receptor regulation in breast cancer ('''Cell''' 2005; '''Nature Genetics''' 2006), Androgen Receptor regulation in prostate cancer ('''Molecular Cell''' 2007; '''Cell''' 2009), chromatin factor FoxA1 in epigenetic regulation ('''Cell''' 2008), Atoh1 in neuron development ('''PNAS''' 2011), fly transcriptome using RNA-seq ('''Genome Res''' 2011), and chimerical RNA biomarkers in prostate cancer ('''PNAS''' 2011). My laboratory also plays an important role in the BCM Epigenomics Data Analysis and Coordination Center for a five-year NIH Roadmap Epigenomics Program.
* Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


   
   

Revision as of 14:37, 13 June 2014

Home        People        Publications        Collaborations        Software        Positions        Contact       


Recent News

. 06/2014: Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to Cell Stem Cell .

. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to Molecular Cell .

. 04/2014: Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in Nucleic Acids Research.

. 02/2014: DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in Cell Stem Cell.

. 02/2014: Zheng's collaborative work on alternative splicing in heart development is accepted to Nature Communications.

. 02/2014: Zheng's brain tumor 3'UTR regulator paper is accepted to Nature. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.

. 02/2014: Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.

. 02/2014: Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to Cell Stem Cell.

. 01/2014: Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to Genome Biology.

. 01/2014: Our collaborative work on Breast Cancer Epigenetics is accepted to Science Translational Medicine.

. 01/2014: Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to Nature. This work links transcription elongation to tumor suppression.

. 12/2013: Kaifu's aging nucleosome paper is accepted to Genes & Development

. 12/2013: We received a 5-year NIH/NHGRI R01 grant (scored at 6 percentile in its first submission) to study DNA Methylation

. 11/2013: Wei will serve on the Editorial Board of Molecular Endocrinology

. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to Nature Genetics.

. 09/2013: Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to Bioinformatics.

. 08/2013: Kadir's p53 paper is accepted to Nucleic Acids Research

. 06/2013: Zheng's TCGA RNA-seq bioinformatics paper is under review in Nature Biotechnology.

. 01/2013: BCM News and Epigenie Headline about our recent work on nucleosome dynamics.

. 12/2012: Liguo and HJ's CPAT RNA coding potential prediction paper is accepted to Nucleic Acids Research.

. 11/2012: Kaifu's nucleosome methodology paper DANPOS is accepted to Genome Research.

. 10/2012: Kaifu's promoter nucleosome paper is accepted to Genome Research.

. 09/2012: A NIH R01 grant was funded. We will work with Dr. Issa at Temple Univ. to understand DNA methylation in Cancer.

. 08/2012: A mouse ES nucleosome paper from Kaestner lab at Upenn is accepted to Cell. Kaifu and Wei used DANPOS to analyze the data and were listed as co-authors.

. 08/2012: Dr. Benjamin Rodriguez will join us as a Postdoc Associate. Ben has PhD in Integrated Biomedical Science from the Ohio State Univ. Welcome!

. 08/2012: A Mazzone Award is funded. We will work with Dr. Balk at Harvard Medical School to understand the molecular features of aggressive prostate cancer.

. 06/2012: Liguo's RNA-seq Quality Control paper is accepted to Bioinformatics.

. 06/2012: A NIH R01 grant is funded. We will work with Dr. Goodell at BCM to understand DNA methylation in Hematopoietic Stem Cell.

. 04/2012: A NIH R01 grant is funded. We will work with Dr. Dent at MD Anderson to define USP22 functions during mammalian development.

. 04/2012: Dr.Dean Tang's prostate cancer stem cell paper is accepted in Cell Stem Cell. Wei is a co-author.

. 02/2012: Yuanxin's epigenetic paper with Katrin Chua lab at Stanford is accepted to Nature. Two years of hard work finally paid off!

. 02/2012: Liguo Wang is offered a tenure-track Assistant Professor position at Mayo Clinic. Congratulations!

. 02/2012: Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!

News Archive




Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.

We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.

In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.

  • Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
  • DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.
  • Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.
  • Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


Lab Intranet openwetware


<html> <script type="text/javascript">

 var _gaq = _gaq || [];
 _gaq.push(['_setAccount', 'UA-5924762-2']);
 _gaq.push(['_trackPageview']);
 (function() {
   var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
   ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
   var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
 })();

</script> </html>